Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sabinsa, a company manufacturing alternative products, has been granted permission by the Indian government to manufacture Ocufors, an eye solution containing naturally derived products.
Subscribe to our email newsletter
This is the first time that the government of India has approved a product developed from natural sources for use as a pharmaceutical grade drug. Ocufors is used in the treatment of glaucoma
The active ingredient in Ocufors, forskolin, is derived from the herb Coleus forskohlii, a plant native to subtropical and warm temperate habitats, and a member of the mint family. Coleus forskohlii is the only known plant source of forskolin, which has traditionally been used to increase lean body mass and optimize body composition.
Currently the company has approximately 10,000 acres dedicated to the cultivation of Coleus forskohlii across various regions in India.
“R&D has always been strength and focus for Sabinsa, and through our ongoing efforts we were able to develop this stable, water- soluble forskolin solution that has been shown in clinical trials to be 30 percent more effective than the most popular glaucoma treatment on the world market today,” noted Dr Muhammed Majeed, founder and CEO of Sabinsa.
Glaucoma is a degenerative disease of the optic nerve, often caused by increased pressure inside the eye. Glaucoma affects more than 50 million individuals worldwide and is the second leading cause of blindness across the globe. Ocufors, which is administered as an eye drop, offers an effective treatment for glaucoma with few to no side effects because it is a natural product made form one percent forskolin.
Sabinsa is currently seeking registration for Ocufors in the US, Europe and Australia.